Cited by 1,743Cytokine Signaling Pathways and InteractionsProtein Tyrosine PhosphatasesNF-κB Signaling Pathways

The DOI matches its Crossref record; 152 of the 152 references it cites were found in a registry or an index.

STATs in oncogenesis

Bowman, Tammy, Garcia, Roy, Turkson, James, Jove, Richard·2000·Oncogene

DOI 10.1038/sj.onc.1203527

Open this paper in CoChat — free account

Abstract

Since their discovery as key mediators of cytokine signaling, considerable progress has been made in defining the structure-function relationships of Signal Transducers and Activators of Transcription (STATs). In addition to their central roles in normal cell signaling, recent studies have demonstrated that diverse oncoproteins can activate specific STATs (particularly Stat3 and Stat5) and that constitutively-activated STAT signaling directly contributes to oncogenesis. Furthermore, extensive surveys of primary tumors and cell lines derived from tumors indicate that inappropriate activation of specific STATs occurs with surprisingly high frequency in a wide variety of human cancers. Together, these findings provide compelling evidence that aberrant STAT activation associated with oncogenesis is not merely adventitious but instead contributes to the process of malignant transformation. These studies are beginning to reveal the molecular mechanisms leading to STAT activation in the context of oncogenesis, and candidate genes regulated by STATs that may contribute to oncogenesis are being identified. Recent studies suggest that activated STAT signaling participates in oncogenesis by stimulating cell proliferation and preventing apoptosis. This review presents the evidence for critical roles of STATs in oncogenesis and discusses the potential for development of novel cancer therapies based on mechanistic understanding of STAT signaling. Oncogene (2000).

Integrity signals

Registry

Crossref · 10.1038/sj.onc.1203527

Cites

152 of 152 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

CDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
Jak-STAT Pathways and Transcriptional Activation in Response to IFNs and Other Extracellular Signaling Proteins
Darnell, J. E., Kerr, L. M., & Stark, G. R. (1994) · Science · doi:10.1126/science.8197455 · Cited by 6,080
STATs and Gene Regulation
Darnell, J. E. (1997) · Science · doi:10.1126/science.277.5332.1630 · Cited by 3,979
HOW CELLS RESPOND TO INTERFERONS
Stark, G. R., Kerr, I. M., Williams, B. R. G., Silverman, R. H., & Schreiber, R. D. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.227 · Cited by 3,932
Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr–Abl positive cells
Druker, B. J., Tamura, S., Buchdunger, E., Ohno-Jones, S., Segal, G. M., Fanning, S., Zimmermann, J., & Lydon, N. (1996) · Nature Medicine · doi:10.1038/nm0596-561 · Cited by 3,652
Stat3 as an Oncogene
Bromberg, J. F., Wrzeszczynska, M. H., Devgan, G., Zhao, Y., Pestell, R. G., Albanese, C., & Darnell, J. E. (1999) · Cell · doi:10.1016/s0092-8674(00)81959-5 · Cited by 2,790
A family of cytokine-inducible inhibitors of signalling
Starr, R., Willson, T. A., Viney, E. M., Murray, L. J. L., Rayner, J. R., Jenkins, B. J., Gonda, T. J., Alexander, W. S., Metcalf, D., Nicola, N. A., et al. (1997) · Nature · doi:10.1038/43206 · Cited by 2,066
Maximal activation of transcription by statl and stat3 requires both tyrosine and serine phosphorylation
Wen, Z., Zhong, Z., & Darnell, J. E. (1995) · Cell · doi:10.1016/0092-8674(95)90311-9 · Cited by 1,974
TRANSCRIPTIONAL RESPONSES TO POLYPEPTIDE LIGANDS: The JAK-STAT Pathway
Schindler, C., & Darnell, J. E. (1995) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.64.070195.003201 · Cited by 1,808
Targeted Disruption of the Stat1 Gene in Mice Reveals Unexpected Physiologic Specificity in the JAK–STAT Signaling Pathway
Meraz, M. A., White, J. M., Sheehan, K. C. F., Bach, E. A., Rodig, S. J., Dighe, A. S., Kaplan, D. H., Riley, J. K., Greenlund, A. C., Campbell, D., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81288-x · Cited by 1,656

Show all 152 references

Research works printed but not linked: 7

Gouilleux-Gruart V, Gouilleux F, Desaint C, Claisse JF, Capiod JC, Delobel J, Weber-Nordt R, Dusanter-Fourt I, Dreyfus F, Groner B and Prin L . 1996 Blood 87: 1692–1697 · DOI
Hallek M, Leif Bergsagel P and Anderson KC . 1998 Blood 91: 3–21 · DOI
Ho JM, Beattie BK, Squire JA, Frank DA and Barber DL . 1999 Blood 93: 4354–4364 · DOI
Liu RY, Fan C, Garcia R, Jove R and Zuckerman KS . 1999 Blood 93: 2369–2379 · DOI
Skorski T, Nieborowska-Skorska M, Wlodarski P, Wasik M, Trotta R, Kanakaraj P, Salomoni P, Antonyak M, Martinez R, Majewski M, Wong A, Perussia B and Calabretta B . 1998 Blood 91: 406–418 · DOI
Sun WH, Pabon C, Alsayed Y, Huang PP, Jandeska S, Uddin S, Platanias LC and Rosen ST . 1998 Blood 91: 570–576 · DOI
Wang YH, Wharton W, Garcia R, Kraker A, Jove R and Pledger WJ . 2000 Oncogene in press

Sorted by citations

Items 601–700 of 999

Expression of Concern: A small molecule, LLL12 inhibits constitutive STAT3 and IL‐6‐induced STAT3 signaling and exhibits potent growth suppressive activity in human multiple myeloma cells
Lin, L., Benson, D. M., DeAngelis, S., Bakan, C. E., Li, P., Li, C., & Lin, J. (2012) · International Journal of Cancer · doi:10.1002/ijc.26152 · Cited by 66
Novel Activation of STAT5b in Response to Epidermal Growth Factor
Kloth, M. T., Catling, A. D., & Silva, C. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111884200 · Cited by 68
Effects of tamoxifen dose and nutrition scheme during growth on stimulation of the reproductive system in cornish breed cocks
Lisowski, M., & Bednarczyk, M. F. (2005) · Folia Biologica · doi:10.3409/1734916054663465 · Cited by 65
Abrogation of constitutive STAT3 activity sensitizes human hepatoma cells to TRAIL-mediated apoptosis
Kusaba, M., Nakao, K., Goto, T., Nishimura, D., Kawashimo, H., Shibata, H., Motoyoshi, Y., Taura, N., Ichikawa, T., Hamasaki, K., et al. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.04.017 · Cited by 63
Stat3 isoforms, α and β, demonstrate distinct intracellular dynamics with prolonged nuclear retention of Stat3β mapping to its unique C-terminal end
Huang, Y., Qiu, J., Dong, S., Redell, M. S., Poli, V., Mancini, M. A., & Tweardy, D. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704548200 · Cited by 65
Celecoxib Inhibits Interleukin-6/Interleukin-6 Receptor–Induced JAK2/STAT3 Phosphorylation in Human Hepatocellular Carcinoma Cells
Liu, Y., Liu, A., Li, H., Li, C., & Lin, J. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0317 · Cited by 65
Stage-specific disruption of Stat3 demonstrates a direct requirement during both the initiation and promotion stages of mouse skin tumorigenesis
Kataoka, K., Kim, D. J., Carbajal, S., Clifford, J. L., & DiGiovanni, J. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn061 · Cited by 66
Cyclin D1 Overexpression and Response to Bortezomib Treatment in a Breast Cancer Model
Ishii, Y., Pirkmaier, A., Alvarez, J. V., Frank, D. A., Keselman, I., Logothetis, D. E., Mandeli, J., O’Connell, M. J., Waxman, S., & Germain, D. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj334 · Cited by 65
Non‐canonical Stat3 signaling in cancer
Srivastava, J., & DiGiovanni, J. (2015) · Molecular Carcinogenesis · doi:10.1002/mc.22438 · Cited by 64
Morusin induces cell death through inactivating STAT3 signaling in prostate cancer cells.
Lim, S.-L., Park, S., Kang, S., Park, D., Kim, S., Um, J., Jang, H.-J., Lee, J., Jeong, C., Jang, J., et al. (2015) · Europe PMC (PubMed Central) · Cited by 65
ERp57 is present in STAT3–DNA complexes
Eufemi, M., Coppari, S., Fabio Altieri, F., Grillo, C., Ferraro, A., & Turano, C. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.09.009 · Cited by 64
Physical and functional interactions between STAT3 and ZIP kinase
Sato, N., Kawai, T., Sugiyama, K., Muromoto, R., Imoto, S., Sekine, Y., Ishida, M., Akira, S., & Matsuda, T. (2005) · International Immunology · doi:10.1093/intimm/dxh331 · Cited by 67
Radioresistance of Brain Tumors
Kelley, K. D., Knisely, J. P. S., Symons, M. H., & Ruggieri, R. (2016) · Cancers · doi:10.3390/cancers8040042 · Cited by 68
DINC: A new AutoDock-based protocol for docking large ligands
Dhanik, A., McMurray, J. S., & Kavraki, L. E. (2013) · BMC Structural Biology · doi:10.1186/1472-6807-13-s1-s11 · Cited by 65
The clinical and biological significance of STAT1 in esophageal squamous cell carcinoma
Zhang, Y., Molavi, O., Su, M., & Lai, R. L. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-791 · Cited by 64
HGF/c-met/Stat3 signaling during skin tumor cell invasion: indications for a positive feedback loop
Syed, Z., Yin, W., Hughes, K., Gill, J. N., Shi, R., & Clifford, J. L. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-180 · Cited by 65
ErbB2-Mediated Src and Signal Transducer and Activator of Transcription 3 Activation Leads to Transcriptional Up-Regulation of p21Cip1 and Chemoresistance in Breast Cancer Cells
Hawthorne, V. S., Huang, W.-C., Neal, C. L., Tseng, L.-M., Hung, M., & Yu, D. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0316 · Cited by 70
γ-Tocotrienol but Not γ-Tocopherol Blocks STAT3 Cell Signaling Pathway through Induction of Protein-tyrosine Phosphatase SHP-1 and Sensitizes Tumor Cells to Chemotherapeutic Agents
Kannappan, R., Yadav, V. R., & Aggarwal, B. B. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.158378 · Cited by 64
Retracted
Increased Bcl-xL expression mediates v-Src-induced resistance to anoikis in intestinal epithelial cells
Loza‐Coll, M., Rosen, K. V., Ladeda, V., & Filmus, J. (2002) · Oncogene · doi:10.1038/sj.onc.1205388 · Cited by 65
The PRMT6/STAT1/ACSL1 axis promotes ferroptosis in diabetic nephropathy
Hong, J. W., Li, X., Hao, Y., Xu, H., Yu, L., Meng, Z., Zhang, J., & Zhu, M. (2024) · Cell Death and Differentiation · doi:10.1038/s41418-024-01357-8 · Cited by 67
Tumor-mediated inhibition of human dendritic cell differentiation and function is consistently counteracted by combined p38 MAPK and STAT3 inhibition
Oosterhoff, D., Lougheed, S. M., van de Ven, R., Lindenberg, J. J., van Cruijsen, H., Hiddingh, L., Kroon, J., van den Eertwegh, A. J. M., Hangalapura, B. N., Scheper, R. J., et al. (2012) · OncoImmunology · doi:10.4161/onci.20365 · Cited by 65
A Novel Small Molecular STAT3 Inhibitor, LY5, Inhibits Cell Viability, Cell Migration, and Angiogenesis in Medulloblastoma Cells
Xiao, H., Bid, H. K., Jou, D., Wu, X., Yu, W., Li, C., Houghton, P. J., & Lin, J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.616748 · Cited by 64
STRA13 Interacts with STAT3 and Modulates Transcription of STAT3-dependent Targets
Ivanova, A. V., Ivanov, S. V., Zhang, X., Ivanov, V. N., Timofeeva, O. A., & Lerman, M. I. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.05.025 · Cited by 63
Selective Activation Of Members Of The Signal Transducers And Activators Of Transcription Family In Prostate Carcinoma
Ni, Z., Lou, W., Lee, S. O. K., Dhir, R., Miguel, F. D., Grandis, J. R., & Gao, A. C. (2002) · The Journal of Urology · doi:10.1016/s0022-5347(05)65249-4 · Cited by 63
Loss-of-Function PTPRD Mutations Lead to Increased STAT3 Activation and Sensitivity to STAT3 Inhibition in Head and Neck Cancer
Peyser, N. D., Du, Y., Li, H., Lui, V. W. Y., Xiao, X., Chan, T. A.-T., & Grandis, J. R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135750 · Cited by 62
The JAK3-selective inhibitor PF-956980 reverses the resistance to cytotoxic agents induced by interleukin-4 treatment of chronic lymphocytic leukemia cells: potential for reversal of cytoprotection by the microenvironment
Steele, A. J., Prentice, A. G., Cwynarski, K., Hoffbrand, A. V., Hart, S., Lowdell, M. W., Samuel, E. R., & Wickremasinghe, R. G. (2010) · Blood · doi:10.1182/blood-2009-09-245811 · Cited by 62
Gefitinib resistance resulted from STAT3-mediated Akt activation in lung cancer cells
Wu, K., Chang, Q., Lu, Y., Qiu, P., Chen, B., Thakur, C., Sun, J., Li, L., Kowluru, A., & Chen, F. (2013) · Oncotarget · doi:10.18632/oncotarget.1431 · Cited by 62
A Small-Molecule Enhancer of Signal Transducer and Activator of Transcription 1 Transcriptional Activity Accentuates the Antiproliferative Effects of IFN-γ in Human Cancer Cells
Lynch, R. A., Etchin, J., Battle, T. E., & Frank, D. A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2439 · Cited by 62
Redox modulation by plant polyphenols targeting vitagenes for chemoprevention and therapy: Relevance to novel anti-cancer interventions and mini-brain organoid technology
Scuto, M. C., Ontario, M. L., Salinaro, A. T., Caligiuri, I., Rampulla, F., Zimbone, V., Modafferi, S., Rizzolio, F., Canzonieri, V., Calabrese, E. J., et al. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.12.267 · Cited by 62
iTRAQ-based comparative proteomic analysis of Vero cells infected with virulent and CV777 vaccine strain-like strains of porcine epidemic diarrhea virus
Guo, X., Hu, H., Chen, F., Li, Z., Ye, S., Cheng, S., Zhang, M., & He, Q. (2015) · Journal of Proteomics · doi:10.1016/j.jprot.2015.09.002 · Cited by 60
Differential expression of STAT5 and Bcl-xL, and high expression of Neu and STAT3 in non-small-cell lung carcinoma
Sánchez-Ceja, S. G., Reyes‐Maldonado, E., Vázquez-Manríquez, M. E., López-Luna, J. J., Belmont, A., & Gutiérrez‐Castellanos, S. (2006) · Lung Cancer · doi:10.1016/j.lungcan.2006.07.012 · Cited by 61
Interleukin-7 (IL-7) and IL-7 receptor (IL-7R) signalling complex in human solid tumours.
Al-Rawi, M. A. A., Mansel, R. E., & Jiang, W. G. (2003) · PubMed · doi:10.14670/hh-18.911 · Cited by 61
Porcine Epidemic Diarrhea Virus-Induced Epidermal Growth Factor Receptor Activation Impairs the Antiviral Activity of Type I Interferon
Yang, L., Xu, J., Guo, L., Guo, T., Zhang, L., Feng, L., Chen, H., & Wang, Y. (2018) · Journal of Virology · doi:10.1128/jvi.02095-17 · Cited by 62
Blockage of the STAT3 signaling pathway with a decoy oligonucleotide suppresses growth of human malignant glioma cells
Gu, J., Li, G., Sun, T., Su, Y., Zhang, X., Shen, J., Tian, Z., & Zhang, J. (2008) · Journal of Neuro-Oncology · doi:10.1007/s11060-008-9590-9 · Cited by 62
Hepatitis B Virus X Protein Activates the p38 Mitogen-Activated Protein Kinase Pathway in Dedifferentiated Hepatocytes
Tarn, C., Zou, L., Hullinger, R. L., & ANDRISANI, O. M. (2002) · Journal of Virology · doi:10.1128/jvi.76.19.9763-9772.2002 · Cited by 59
Molecular Alterations in Oral Carcinogenesis: Significant Risk Predictors in Malignant Transformation and Tumor Progression
Shah, N. G., Trivedi, T. I., Tankshali, R. A., Goswami, J., Shah, J., Jetly, D., Kobawala, T. P., Patel, K. C., Shukla, S. N., Shah, P. M., et al. (2007) · The International Journal of Biological Markers · doi:10.5301/jbm.2008.4745 · Cited by 67
Cyclin-dependent kinase 5 modulates STAT3 and androgen receptor activation through phosphorylation of Ser 727 on STAT3 in prostate cancer cells
Hsu, F.-N., Chen, M., Lin, K., Peng, Y.-T., Li, P.-C., Lin, E., Chiang, M.-C., Hsieh, J., & Lin, H. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00615.2012 · Cited by 63
Histone deacetylase 1/2 mediates proliferation of renal interstitial fibroblasts and expression of cell cycle proteins
Pang, M., Ma, L., Liu, N., Ponnusamy, M., Zhao, T. C., Yan, H., & Zhuang, S. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23135 · Cited by 60
Flavopiridol disrupts STAT3/DNA interactions, attenuates STAT3-directed transcription, and combines with the Jak kinase inhibitor AG490 to achieve cytotoxic synergy
Lee, Y. K., Isham, C. R., Kaufmann, S. H., & Bible, K. C. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0235 · Cited by 62
Luteolin Induces Carcinoma Cell Apoptosis through Binding Hsp90 to Suppress Constitutive Activation of STAT3
Fu, J., Chen, D., Zhao, B., Zhao, Z., Zhou, J., Xu, Y., Xin, Y., Liu, C., Luo, L., & Yin, Z. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049194 · Cited by 59
Combined gamma-tocotrienol and erlotinib/gefitinib treatment suppresses Stat and Akt signaling in murine mammary tumor cells.
Bachawal, S. V., Wali, V. B., & Sylvester, P. W. (2010) · PubMed · Cited by 60
Apigenin induces apoptosis by suppressing Bcl-xl and Mcl-1 simultaneously via signal transducer and activator of transcription 3 signaling in colon cancer
Maeda, Y., Takahashi, H., Nakai, N., Yanagita, T., Ando, N., Okubo, T., Saito, K., Shiga, K., Hirokawa, T., Hara, M., et al. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4308 · Cited by 60
Interleukin 13: A Growth Factor in Hodgkin Lymphoma
Skinnider, B., Kapp, U., & Mak, T. W. (2001) · International Archives of Allergy and Immunology · doi:10.1159/000049523 · Cited by 59
8p12 Stem Cell Myeloproliferative Disorder: the FOP-Fibroblast Growth Factor Receptor 1 Fusion Protein of the t(6;8) Translocation Induces Cell Survival Mediated by Mitogen-Activated Protein Kinase and Phosphatidylinositol 3-Kinase/Akt/mTOR Pathways
Guasch, G., Ollendorff, V., Borg, J., Birnbaum, D., & Pébusque, M. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.23.8129-8142.2001 · Cited by 58
15-PGJ2, but not thiazolidinediones, inhibits cell growth, induces apoptosis, and causes downregulation of Stat3 in human oral SCCa cells
Nikitakis, N. G., Siavash, H., Hebert, C. G., Reynolds, M. A., Hamburger, A. W., & Sauk, J. J. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600618 · Cited by 60
Reduced phosphorylation of Stat3 at Ser-727 mediated by casein kinase 2 - protein phosphatase 2A enhances Stat3 Tyr-705 induced tumorigenic potential of glioma cells
Mandal, T., Bhowmik, A., Chatterjee, A., Chatterjee, U., Chatterjee, S., & Ghosh, M. K. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.04.003 · Cited by 65
Conformationally Constrained Peptidomimetic Inhibitors of Signal Transducer and Activator of Transcription 3: Evaluation and Molecular Modeling
Mandal, P. K., Limbrick, D., Coleman, D. R., Dyer, G. A., Ren, Z., Birtwistle, J. S., Xiong, C., Chen, X., Briggs, J. M., & McMurray, J. S. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm801491w · Cited by 59
Chromatin Dynamics of Gene Activation and Repression in Response to Interferon α (IFNα) Reveal New Roles for Phosphorylated and Unphosphorylated Forms of the Transcription Factor STAT2
Testoni, B., Voellenkle, C., Guerrieri, F., Gerbal‐Chaloin, S., Blandino, G., & Levrero, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.231068 · Cited by 62
Stat3 upregulates MEK5 expression in human breast cancer cells
Song, H., Jin, X., & Lin, J. (2004) · Oncogene · doi:10.1038/sj.onc.1208026 · Cited by 59
Dramatic Antitumor Effects of the Dual MET/RON Small-Molecule Inhibitor LY2801653 in Non–Small Cell Lung Cancer
Kawada, I., Hasina, R., Arif, Q., Mueller, J. S., Smithberger, E., Husain, A. N., Vokes, E. E., & Salgia, R. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3583 · Cited by 59
Janus kinase inhibitor INCB20 has antiproliferative and apoptotic effects on human myeloma cellsin vitroandin vivo
Burger, R., Gouill, S. L., Tai, Y., Shringarpure, R., Tassone, P., Neri, P., Podar, K., Catley, L. P., Hideshima, T., Chauhan, D., et al. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0149 · Cited by 59
Targeting Signal Transducer and Activator of Transcription 3 Pathway by Cucurbitacin I Diminishes Self-Renewing and Radiochemoresistant Abilities in Thyroid Cancer-Derived CD133+ Cells
Tseng, L., Huang, P., Chen, Y.-R., Chen, Y., Chou, Y.-C., Chen, Y., Chang, Y.-L., Hsu, H., Lan, Y., Chen, K.-H., et al. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.188730 · Cited by 60
Physalin A exerts anti-tumor activity in non-small cell lung cancer cell lines by suppressing JAK/STAT3 signaling
Zhu, F., Dai, C., Fu, Y., Loo, J. F.-C., Xia, D., Gao, S. P., Ma, Z., & Chen, Z. (2016) · Oncotarget · doi:10.18632/oncotarget.7051 · Cited by 60
A panoramic review and in silico analysis of IL-11 structure and function
Negahdaripour, M., Nezafat, N., & Ghasemi, Y. (2016) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2016.06.002 · Cited by 59
Cryptotanshinone inhibits human glioma cell proliferation in vitro and in vivo through SHP-2-dependent inhibition of STAT3 activation
Lu, L., Zhang, S., Li, C., Zhou, C., Li, D., Liu, P., Huang, M., & Shen, X. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.174 · Cited by 59
Cellular signaling pathways engaged by the Epstein-Barr virus transforming protein LMP1
Hatzivassiliou, E. (2002) · Frontiers in bioscience · doi:10.2741/hatziva · Cited by 59
Importance of STAT3 signaling in preeclampsia (Review)
Marzioni, D., Piani, F., Simone, N. D., Giannubilo, S. R., Ciavattini, A., & Tossetta, G. (2025) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2025.5499 · Cited by 61
Alkylation of Cysteine 468 in Stat3 Defines a Novel Site for Therapeutic Development
Buettner, R., Corzano, R., Rashid, R., Lin, J., Senthil, M., Hedvat, M., Schroeder, A., Mao, A., Herrmann, A., Yim, J. H., et al. (2011) · ACS Chemical Biology · doi:10.1021/cb100253e · Cited by 58
Self-citation
Human Prostatic Acid Phosphatase, an Authentic Tyrosine Phosphatase, Dephosphorylates ErbB-2 and Regulates Prostate Cancer Cell Growth
Chuang, T., Chen, S.-J., Lin, F., Veeramani, S., Kumar, S., Batra, S. K., Tu, Y., & Lin, M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.098301 · Cited by 58
IL-21 Contributes to JAK3/STAT3 Activation and Promotes Cell Growth in ALK-Positive Anaplastic Large Cell Lymphoma
Bard, J. D., Gélébart, P., Anand, M., Zak, Z., Hegazy, S. A., Amin, H. M., & Lai, R. L. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080982 · Cited by 59
Identification of a non-phosphorylated, cell permeable, small molecule ligand for the Stat3 SH2 domain
Page, B. D. G., Fletcher, S., Yue, P., Li, Z., Zhang, X., Sharmeen, S., Datti, A., Wrana, J. L., Trudel, S., Schimmer, A. D., et al. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.06.056 · Cited by 58
Self-citation
Association of JAK‐STAT pathway related genes with lymphoma risk: results of a European case–control study (EpiLymph)
Butterbach, K., Beckmann, L., de Sanjosé, S., Benavente, Y., Becker, N., Foretová, L., Maynadié, M., Cocco, P., Staines, A. S., Boffetta, P., et al. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2011.08632.x · Cited by 58
Diindolylmethane suppresses ovarian cancer growth and potentiates the effect of cisplatin in tumor mouse model by targeting signal transducer and activator of transcription 3 (STAT3)
Kandala, P. K., & Srivastava, S. (2012) · BMC Medicine · doi:10.1186/1741-7015-10-9 · Cited by 58
Targeting Janus kinase 3 to attenuate the severity of acute graft-versus-host disease across the major histocompatibility barrier in mice
Ćetković-Cvrlje, M., Roers, B. A., Waurzyniak, B. J., Liu, X., & Uckun, F. M. (2001) · Blood · doi:10.1182/blood.v98.5.1607 · Cited by 58
Competing endogenous RNAs in lung cancer
Zhao, M., Feng, J., & Tang, L. (2021) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2020.0203 · Cited by 61
Stat3 modulates heat shock 27 kDa protein expression in breast epithelial cells
Song, H., Ethier, S. P., Dziubinski, M. L., & Lin, J. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.12.048 · Cited by 60
Src family kinases promote AML cell survival through activation of signal transducers and activators of transcription (STAT)
Ozawa, Y., Williams, A. H., Estes, M. L., Matsushita, N., Boschelli, F., Jove, R., & List, A. F. (2008) · Leukemia Research · doi:10.1016/j.leukres.2007.11.032 · Cited by 57
Self-citation
Novel high-throughput screening system for identifying STAT3–SH2 antagonists
Uehara, Y., Mochizuki, M., Matsuno, K., Haino, T., & Asai, A. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.01.137 · Cited by 57
STAT3 supports experimental K-RasG12D–induced murine myeloproliferative neoplasms dependent on serine phosphorylation
Gough, D. J., Marié, I. J., Lobry, C., Aifantis, I., & Levy, D. E. (2014) · Blood · doi:10.1182/blood-2013-02-484196 · Cited by 58
Discovery of potent anticancer agent HJC0416, an orally bioavailable small molecule inhibitor of signal transducer and activator of transcription 3 (STAT3)
Chen, H., Yang, Z., Ding, C., Xiong, A., Wild, C., Wang, L., Ye, N., Cai, G., Flores, R. M., Ding, Y., et al. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.05.049 · Cited by 58
Lytic Viral Replication as a Contributor to theDetection of Epstein-Barr Virus in BreastCancer
Huang, J., Chen, H.-W., Hutt‐Fletcher, L. M., Ambinder, R. F., & Hayward, S. D. (2003) · Journal of Virology · doi:10.1128/jvi.77.24.13267-13274.2003 · Cited by 57
Physiologically achievable concentrations of genistein enhance telomerase activity in prostate cancer cells via the activation of STAT3
Chau, M. N., Touny, L. H. E., Jagadeesh, S., & Banerjee, P. P. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm148 · Cited by 56
Activation of STAT5 triggers proliferation and contributes to anti-apoptotic signalling mediated by the oncogenic Xmrk kinase
Morcinek, J. C., Weisser, C., Geissinger, E., Schartl, M., & Wellbrock, C. (2002) · Oncogene · doi:10.1038/sj.onc.1205148 · Cited by 56
Spatio-temporal modeling of signaling protein recruitment to EGFR
Hsieh, M.-Y., Yang, S., Raymond‐Stintz, M. A., Edwards, J. S., & Wilson, B. S. (2010) · BMC Systems Biology · doi:10.1186/1752-0509-4-57 · Cited by 56
Hematopoietic perturbation in zebrafish expressing a tel-jak2a fusion
Onnebo, S. M. N., Condron, M. M., McPhee, D., Lieschke, G. J., & Ward, A. C. (2005) · Experimental Hematology · doi:10.1016/j.exphem.2004.10.019 · Cited by 56
The GRIMs: a new interface between cell death regulation and interferon/retinoid induced growth suppression
Kalvakolanu, D. V. (2004) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2004.01.002 · Cited by 56
Signal transducers and activators of transcription—from cytokine signalling to cancer biology
Santos, C. I., & Costa‐Pereira, A. P. (2011) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2011.03.003 · Cited by 59
Inhibition of Constitutive Activation of STAT3 by Curcurbitacin-I (JSI-124) Sensitized Human B-Leukemia Cells to Apoptosis
Ishdorj, G., Johnston, J. B., & Gibson, S. B. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0550 · Cited by 57
Active Stat3 is required for survival of human squamous cell carcinoma cells in serum-free conditions
Yin, W., Cheepala, S., Roberts, J. N., Chan, K. S., DiGiovanni, J., & Clifford, J. L. (2006) · Molecular Cancer · doi:10.1186/1476-4598-5-15 · Cited by 56
Connexin32 as a tumor suppressor gene in a metastatic renal cell carcinoma cell line
Fujimoto, E., Sato, H., Shirai, S., Nagashima, Y., Fukumoto, K., Hagiwara, H., Negishi, E., Ueno, K., Omori, Y., Yamasaki, H., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208430 · Cited by 55
Mechanism of Action of a Novel Latent Membrane Protein-1 Dominant Negative
Brennan, P., Floettmann, J. E., Mehl, A. M., Jones, M. D., & Rowe, M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m005461200 · Cited by 56
Targeting STAT3 signaling overcomes gefitinib resistance in non-small cell lung cancer
Liu, Z., Ma, L., Sun, Y., Yu, W., & Wang, X. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03844-z · Cited by 55
Differential Expression of STAT1 and p21 Proteins Predicts Pancreatic Cancer Progression and Prognosis
Sun, Y., Yang, S., Sun, N., & Chen, J. (2014) · Pancreas · doi:10.1097/mpa.0000000000000074 · Cited by 55
Pyruvate kinase M2 affects liver cancer cell behavior through up-regulation of HIF-1α and Bcl-xL in culture
Dong, T., Yan, Y., Chai, H., Chen, S., Xiong, X., Sun, D., Yu, Y., Deng, L., & Cheng, F. (2014) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2014.12.010 · Cited by 58
miR-21 regulates tumor progression through the miR-21-PDCD4-Stat3 pathway in human salivary adenoid cystic carcinoma
Jiang, L., Ge, M., Hou, X., Cao, J., Hu, S., Lu, X., Han, J., Wu, Y., Liu, X., Zhu, X., et al. (2015) · Laboratory Investigation · doi:10.1038/labinvest.2015.105 · Cited by 55
Cytokine networks and their association with Helicobacter pylori infection in gastric carcinoma
Bagheri, V., Memar, B., Momtazi‐Borojeni, A. A., Sahebkar, A., Gholamin, M., & Abbaszadegan, M. R. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25822 · Cited by 56
Constitutive activation of STAT proteins in the HDLM-2 and L540 Hodgkin lymphoma-derived cell lines supports cell survival
Cochet, O., Frelin, C., Peyron, J., & Imbert, V. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2005.05.010 · Cited by 55
Differential methylation of genes that regulate cytokine signaling in lymphoid and hematopoietic tumors
Reddy, J., Shivapurkar, N., Takahashi, T., Parikh, G. Y., Stastny, V., Echebiri, C., Crumrine, K., Zöchbauer‐Müller, S., Drach, J. W., Zheng, Y., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1208032 · Cited by 55
Identification of Cellular Intermediates and Molecular Pathways Induced by IL-21 in Human B Cells
Konforte, D., & Paige, C. J. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.12.8381 · Cited by 55
Transcriptional regulators in mammary gland development and cancer
Visvader, J. E., & Lindeman, G. J. (2003) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(03)00030-x · Cited by 55
Combined inhibition of JAK1/2 and DNMT1 by newly identified small-molecule compounds synergistically suppresses the survival and proliferation of cervical cancer cells
She, S., Zhao, Y., Kang, B., Cheng, C., Chen, X., Zhang, X., Chen, W., Dan, S., Wang, H., Wang, Y., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-02934-8 · Cited by 54
EGFR targeted therapies and radiation: Optimizing efficacy by appropriate drug scheduling and patient selection
Cuneo, K. C., Nyati, M. K., Ray, D., & Lawrence, T. S. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.07.002 · Cited by 57
Suppression of Stat3 activity sensitizes gefitinib-resistant non small cell lung cancer cells
Chiu, H.-C., Chou, D.-L., Huang, C.-T., Lin, W., Lien, T., Yen, K.-J., & Hsu, J. T.-A. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.03.003 · Cited by 56
Pyk2 Amplifies Epidermal Growth Factor and c-Src-induced Stat3 Activation
Shi, C.-S., & Kehrl, J. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311875200 · Cited by 55
Effects of hnRNP A2/B1 Knockdown on Inhibition of Glioblastoma Cell Invasion, Growth and Survival
Deng, J., Chen, S., Wang, F., Zhao, H., Xie, Z., Xu, Z., Zhang, Q., Liang, P., Zhai, X., & Cheng, Y. Z. (2015) · Molecular Neurobiology · doi:10.1007/s12035-014-9080-3 · Cited by 55
The Chemopreventive Phytochemical Moringin Isolated from Moringa oleifera Seeds Inhibits JAK/STAT Signaling
Michl, C., Vivarelli, F., Weigl, J., Nicola, G. R. D., Canistro, D., Paolini, M., Iori, R., & Rascle, A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0157430 · Cited by 54
XIST/miR‐544 axis induces neuropathic pain by activating STAT3 in a rat model
Jin, H., Du, X., Zhao, Y., & Xia, D. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.26376 · Cited by 54
The critical role that STAT3 plays in glioma-initiating cells: STAT3 addiction in glioma
Ganguly, D., Fan, M., Yang, C. H., Zbytek, B., Finkelstein, D., Roussel, M. F., & Pfeffer, L. M. (2018) · Oncotarget · doi:10.18632/oncotarget.25188 · Cited by 57
Feedback activation of STAT3 limits the response to PI3K/AKT/mTOR inhibitors in PTEN-deficient cancer cells
Wang, J., Lv, X., Guo, X., Dong, Y., Peng, P., Huang, F., Wang, P., Zhang, H. M., Zhou, J., Wang, Y., et al. (2021) · Oncogenesis · doi:10.1038/s41389-020-00292-w · Cited by 57
Stat5 in the mammary gland: Controlling normal development and cancer
Barash, I. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20771 · Cited by 54

Authors: Bowman, T., Garcia, R., Turkson, J., & Jove, R.
Affiliations: Moffitt Cancer Center (US)
University of South Florida (US)
ORCID: Turkson, James
Venue: Oncogene
Publisher: Springer Science and Business Media LLC
Published: 2000-05-25
Volume: 19
Issue: 21
Pages: 2474-2488
ISSN: 0950-9232 (ISSN-L)
1476-5594
DOI: 10.1038/sj.onc.1203527
OpenAlex: W2024282024
Cited by: 1,743
References: 152
Citations by year: 2026: 16 · 2025: 18 · 2024: 18 · 2023: 22 · 2022: 39 · 2021: 48 · 2020: 44 · 2019: 45 · 2018: 59 · 2017: 63 · 2016: 58 · 2015: 104 · 2014: 80 · 2013: 82 · 2012: 89
FWCI: 7.25
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Oncogene (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
Keywords: STAT, signal transducer and activator of transcription, carcinogenesis, STAT3, STAT5, malignant transformation, cytokine signaling, cell proliferation, apoptosis, cancer therapy targets, cancer cell lines
MeSH terms: Animals, Cell Transformation, Neoplastic, DNA-Binding Proteins, Humans, Neoplasms, Phosphorylation, Phosphoserine, Protein-Tyrosine Kinases, Signal Transduction, Oncogene Proteins, Trans-Activators, Gene Expression Regulation, Neoplastic, STAT1 Transcription Factor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

STATs in oncogenesis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks